JP2021522163A5 - - Google Patents
Info
- Publication number
- JP2021522163A5 JP2021522163A5 JP2020556946A JP2020556946A JP2021522163A5 JP 2021522163 A5 JP2021522163 A5 JP 2021522163A5 JP 2020556946 A JP2020556946 A JP 2020556946A JP 2020556946 A JP2020556946 A JP 2020556946A JP 2021522163 A5 JP2021522163 A5 JP 2021522163A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- release composition
- mol
- liposome
- sustained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862661217P | 2018-04-23 | 2018-04-23 | |
| US62/661,217 | 2018-04-23 | ||
| PCT/US2019/028647 WO2019209787A1 (en) | 2018-04-23 | 2019-04-23 | Inhalable liposomal sustained release composition for use in treating pulmonary diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021522163A JP2021522163A (ja) | 2021-08-30 |
| JP2021522163A5 true JP2021522163A5 (enExample) | 2022-04-19 |
| JP7391039B2 JP7391039B2 (ja) | 2023-12-04 |
Family
ID=66821301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020556946A Active JP7391039B2 (ja) | 2018-04-23 | 2019-04-23 | 肺疾患の処置に使用するための吸入可能なリポソーム徐放性組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11534399B2 (enExample) |
| EP (1) | EP3784213B1 (enExample) |
| JP (1) | JP7391039B2 (enExample) |
| KR (1) | KR20210003197A (enExample) |
| CN (1) | CN112004527B (enExample) |
| AU (1) | AU2019261329B2 (enExample) |
| BR (1) | BR112020021412A8 (enExample) |
| CA (1) | CA3101102A1 (enExample) |
| ES (1) | ES2964413T3 (enExample) |
| IL (1) | IL278079B2 (enExample) |
| TW (1) | TWI866908B (enExample) |
| WO (1) | WO2019209787A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3784213B1 (en) | 2018-04-23 | 2023-09-06 | InspirMed Corp. | Inhalable liposomal sustained release composition for use in treating pulmonary diseases |
| TWI786328B (zh) * | 2018-09-10 | 2022-12-11 | 台灣微脂體股份有限公司 | 緩釋眼用藥物組合物及其用途 |
| US12599557B2 (en) | 2019-04-25 | 2026-04-14 | Tlc Biopharmaceuticals, Inc. | Liposomal sustained-release compositions containing a therapeutic drug and use thereof |
| TWI853932B (zh) * | 2019-05-14 | 2024-09-01 | 盈擘生技股份有限公司 | 用於治療肺部疾病之可吸入的支氣管擴張劑緩釋組成物 |
| WO2021194927A1 (en) * | 2020-03-22 | 2021-09-30 | Tlc Biopharmaceuticals, Inc. | Composition of antiviral agent for use in prophylactic or post-exposure treatment of infectious or respiratory diseases |
| CN112472791A (zh) * | 2020-11-16 | 2021-03-12 | 复旦大学 | CsA脂质体在制备抗SARS-CoV-2药物中的应用 |
| EP4259101A4 (en) * | 2020-12-14 | 2024-11-27 | Nanotech Pharma Inc. | COMPOSITIONS AND METHODS FOR DELIVERY OF ANTICANCER AGENTS WITH IMPROVED THERAPEUTIC INDEX |
| CN114642656B8 (zh) * | 2020-12-18 | 2025-12-12 | 盈科瑞（天津）创新医药研究有限公司 | 一种吸入用尼达尼布溶液及其制备方法 |
| US20250325549A1 (en) * | 2021-08-18 | 2025-10-23 | Samyang Holdings Corporation | Oral tablet composition of ruxolitinib and method for preparing same |
| KR102348901B1 (ko) | 2021-08-26 | 2022-01-07 | 충북대학교 산학협력단 | 레고라페닙을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물 |
| CN116064394A (zh) * | 2021-11-01 | 2023-05-05 | 中国医学科学院医药生物技术研究所 | 肿瘤细胞外泌体与脂质体的杂化外泌体、其制备方法及其抗肿瘤用途 |
| JP2025069482A (ja) * | 2022-03-25 | 2025-05-01 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 特発性肺線維症の治療または予防剤 |
| CN120076792A (zh) * | 2022-09-30 | 2025-05-30 | 上海济昀生物科技有限公司 | 一种脂质体药物组合物及其制备方法和应用 |
| BE1031669B1 (fr) * | 2023-06-02 | 2025-01-14 | Inhatarget Therapeutics | Composition pharmaceutique pour inhalation |
| EP4637764A1 (en) * | 2023-12-22 | 2025-10-29 | Zedira GmbH | Oxo-pyridine derivatives as inhibitors of transglutaminases for use in the treatment of pulmonary fibrosis |
| WO2025138298A1 (zh) * | 2023-12-30 | 2025-07-03 | 北京睿创康泰医药研究院有限公司 | 一种尼达尼布超分子复合体的药物组合物 |
| CN117899020A (zh) * | 2024-01-16 | 2024-04-19 | 中山大学 | 一种载抗生素黏液渗透型脂质体粉雾剂的制备方法及其应用 |
| CN118948812A (zh) * | 2024-08-06 | 2024-11-15 | 北京悦康科创医药科技股份有限公司 | 一种多肽脂质体吸入剂及其制备方法和应用 |
| KR102859152B1 (ko) * | 2024-10-24 | 2025-09-12 | 주식회사 한국리포좀 | 합성 지질 리포좀 기반의 일본 뇌염 바이러스 백신 및 그의 제조방법 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63500175A (ja) | 1985-05-22 | 1988-01-21 | リポソ−ム テクノロジ−，インコ−ポレイテツド | リポソ−ム吸入法および吸入システム |
| IE63869B1 (en) | 1986-11-06 | 1995-06-14 | Res Dev Foundation | Aerosols containing liposomes and method for their preparation |
| US5958378A (en) | 1996-07-03 | 1999-09-28 | Research Development Foundation | High dose liposomal aerosol formulations containing cyclosporin A or budesonide |
| GB9912639D0 (en) | 1999-05-28 | 1999-07-28 | Britannia Pharmaceuticals Ltd | Improvements in and relating to treatment of respiratory conditions |
| DE10214983A1 (de) | 2002-04-04 | 2004-04-08 | TransMIT Gesellschaft für Technologietransfer mbH | Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen |
| DE10237423A1 (de) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| PT1581236E (pt) | 2002-10-29 | 2013-12-24 | Insmed Inc | Libertação prolongada de anti-infecciosos |
| US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| EP1628637A2 (en) | 2003-05-30 | 2006-03-01 | Alza Corporation | Method of pulmonary administration of an agent |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| EP3067047B1 (en) | 2005-12-08 | 2022-04-20 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections |
| US8268347B1 (en) | 2006-10-24 | 2012-09-18 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
| US8119156B2 (en) | 2006-10-24 | 2012-02-21 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
| US8071127B2 (en) | 2006-10-24 | 2011-12-06 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
| US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
| CN101878229A (zh) * | 2007-09-28 | 2010-11-03 | 巴塞尔大学医院 | 用于治疗癌症的免疫脂质体 |
| US9233971B2 (en) * | 2010-08-26 | 2016-01-12 | Kunyuan Cui | Lipomacrocycles and uses thereof |
| JP2013537172A (ja) | 2010-09-09 | 2013-09-30 | トリフォイリウム エーピーエス | 血管新生阻害剤の気道投与 |
| MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| WO2014121211A2 (en) * | 2013-02-01 | 2014-08-07 | Zoneone Pharma, Inc. | Remote loading of sparingly water-soluble drugs into liposomes |
| EP3782604A1 (en) * | 2013-07-31 | 2021-02-24 | Windward Pharma, Inc. | Aerosol tyrosine kinase inhibitor compounds and uses thereof |
| KR20150026613A (ko) * | 2013-09-03 | 2015-03-11 | 삼성전자주식회사 | 소수성 물질 및 조영제를 포함하는 리포좀 및 그의 용도 |
| AU2015204558B2 (en) | 2014-01-10 | 2020-04-30 | Avalyn Pharma Inc. | Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| WO2016090111A1 (en) | 2014-12-05 | 2016-06-09 | Vindico NanoBio Technology Inc. | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
| WO2016178064A1 (en) | 2015-05-06 | 2016-11-10 | Suven Life Sciences Limited | Polymorph of nintedanib ethanesulphonate, processes and intermediates thereof |
| US20180344644A1 (en) * | 2015-09-21 | 2018-12-06 | Mallinckrodt Llc | Improved stability of liposome formulations and uses thereof |
| EP4218739A3 (en) * | 2016-01-08 | 2023-08-09 | The Regents of The University of California | Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery |
| WO2017136774A1 (en) * | 2016-02-04 | 2017-08-10 | Stem Cell Theranostics, Inc. | Pharmaceutical compositions and methods for countering chemotherapy induced cardiotoxicity |
| EP3784213B1 (en) | 2018-04-23 | 2023-09-06 | InspirMed Corp. | Inhalable liposomal sustained release composition for use in treating pulmonary diseases |
-
2019
- 2019-04-23 EP EP19729872.2A patent/EP3784213B1/en active Active
- 2019-04-23 IL IL278079A patent/IL278079B2/en unknown
- 2019-04-23 WO PCT/US2019/028647 patent/WO2019209787A1/en not_active Ceased
- 2019-04-23 ES ES19729872T patent/ES2964413T3/es active Active
- 2019-04-23 BR BR112020021412A patent/BR112020021412A8/pt unknown
- 2019-04-23 KR KR1020207033553A patent/KR20210003197A/ko not_active Ceased
- 2019-04-23 CN CN201980027748.1A patent/CN112004527B/zh active Active
- 2019-04-23 TW TW108114188A patent/TWI866908B/zh active
- 2019-04-23 AU AU2019261329A patent/AU2019261329B2/en active Active
- 2019-04-23 CA CA3101102A patent/CA3101102A1/en active Pending
- 2019-04-23 US US17/045,940 patent/US11534399B2/en active Active
- 2019-04-23 JP JP2020556946A patent/JP7391039B2/ja active Active
-
2022
- 2022-11-22 US US17/992,481 patent/US12533313B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522163A5 (enExample) | ||
| IL278079B1 (en) | Inhalable liposomal sustained release compound for use in the treatment of pulmonary diseases | |
| JP6974670B2 (ja) | 弱酸性薬物を含むリポソーム組成物およびその使用 | |
| JP6357481B2 (ja) | プロスタサイクリン化合物およびプロスタサイクリン化合物を使用する方法 | |
| US5741516A (en) | Sphingosomes for enhanced drug delivery | |
| WO2015138423A1 (en) | Prostacylin compositions and methods for using the same | |
| JP4833836B2 (ja) | リポソーム製剤 | |
| TWI757739B (zh) | 包含弱酸藥物之醫藥組成物及其用途 | |
| WO2010095964A1 (en) | A method for amphiphilic drug loading in liposomes by ion gradient | |
| JP4874097B2 (ja) | 水難溶性カンプトテシン含有リポソーム製剤 | |
| US11083693B1 (en) | Liposome formulation of vilanterol trifenatate | |
| HK40043569A (en) | Inhalable liposomal sustained release composition for use in treating pulmonary diseases | |
| TW202604536A (zh) | 霧化器套組及其用途 | |
| US20210059937A1 (en) | Liposome Formulation of Fluticasone Furoate and Method of Preparation | |
| TW202547521A (zh) | 全身性硬化症與凍傷的吸入治療方法 | |
| WO2025264889A1 (en) | Nebulizer kits and uses thereof | |
| HK40043569B (zh) | 用於治疗肺部疾病的可吸入脂质体缓释组合物 | |
| Johnston | Studies of factors influencing drug efflux rates from liposomes and their impact on antitumor efficacy |